el_mic.png
SPEAKERS
0 K+
mdi_people-group.png
ATTENDEES
0 K+
teenyicons_chat-typing-solid.png
TOPICS
0 K+
Vector.png
SPONSOR
0 K+

CONFERENCE OVERVIEW

41st Pharmacovigilance USA 2026

Key Focus Areas

5 REASONS TO ATTEND THE EVENT

UNLOCK OPPORTUNITIES, INSIGHTS,

AND CONNECTIONS THAT MATTER

At Business, we bring together brightest minds, leaders, and trailblazers from across industries to explore latest trends, technologies, and strategies shaping the future.

Knowledge

Gain insights from experts, researchers, and professionals on the latest pharma advancements.Knowledge Gain insights from experts, researchers, and professionals on the latest pharma advancements.

An Agenda Made For You

High quality content that addresses your biggest challenges and uncovering hidden opportunities.Explore the latest trends, innovations, and breakthroughs driving the future of the pharmaceutical industry.

Cutting-Edge Insights

Explore the latest trends, innovations, and breakthroughs driving the future of the pharmaceutical industry.

Networking

Connect with peers, industry leaders, and collaborators to exchange ideas and explore new opportunities.

Practical Takeaways

Walk away with practical strategies, case studies, and proven best practices to apply in real-time.

our attendess

Trusted by Industry Leaders Worldwide

Join a prestigious network of global companies that regularly participate, collaborate, and drive meaningful change at our conferences.

events speakers

MARIETTE BOERSTOEL-STREEFLAND

Bristol-Myers Squibb

PHILISHA MACK

Azurity Pharmaceuticals

E. ALTON SARTOR

AstraZeneca

NICOLE SCHUMACHER-CROW

Pfizer

HARSHA SHETTY

CSL Behring

KARTHIK MUTHUSAMY

Novo Nordisk

DEANNA MONTES DE OCA

Moderna

WENDY ERLER

Sarepta Therapeutics

EDDIE DARTON

Sarepta Therapeutics

SUSAN WNOROWSKI

Ipsen

SHALINI PATEL

Moderna

MICHAEL GLASER

GSK

MICHELE COIRO

Bristol-Myers Squibb

VASUDEV BHUPATHI

Moderna

ALLISON CONCANNON

Ipsen

JULIE BARBERIO

Sanofi

VIKALP KHARE

Otsuka Pharmaceutical

ASHRAF YOUSSEF

Takeda Pharmaceuticals

SHEFALI JOBANPUTRA

Takeda

TEODORA DOHERTY

Janssen R&D

BEN LOCWIN

SOPPhC

MILIND SARDESA

Dicerna Pharmaceuticals

SUMIT MUNJAL

Otsuka Pharmaceutical

KAL ELHOREGY

Amneal Pharmaceuticals

WILLIAM A. BLUMENTALS

Sanofi

PRIYANKA CHHIKARA

CSL Behring

MALLIKA SINGH

Genetix Biotherapeutics

KAPIL BHUTADA

Asklepios BioPharmaceutical

ANUJ PARIKH

Jazz Pharmaceuticals

NAMITA JOSHI

Sanofi

SANDY (BAUTE) DIAZ

Novo Nordisk

REEM YASIN

Hawkary Pharmaceuticals, Kawkab group (Iraq)

HEATHER LEIGH FLANNERY

AI MINDSystems Foundation

VINEET SINGH

CSL Behring

NINA TEO

Alnylam Pharmaceuticals

OUR EVENT SCHEDULE

09:00 – Chairperson opening remarks

Registration & Refreshments

Kick off your conference experience by checking in at our registration desk. Collect your event materials and enjoy a selection of refreshments. It’s the perfect time to mingle with fellow attendees and set the tone for an engaging and informative event

09:00 – Chairperson opening remarks

BEN LOCWIN

VP Board of Directors
SOPPhC (VP, Reliant Life Sciences)

09:10 – AI Agents Transforming Safety, Reporting, and
Operations

DATA TO DECISIONS

  • Medical AI Agent for Adverse Event Assessment
  • From Data to Draft: A Proof-of-Concept Agent for AI – Assisted Aggregate Report Writing
  • An AI Agent for Intelligent Navigation of Company Procedures

PRIYANKA CHHIKARA

Head of Risk Management, Aggregate Reports & Data
Science, CSL Behring

VINEET SINGH

Head of PV Data Science and Analytics
CSL Behring

09:40 – Real World Data to Real World Evidence

RWD / RWE

  • Importance of real-world data for answering regulatory questions
  • Benefits and challenges of evidence derived from real world sources
  • Real World Evidence: How Does its Use challenge quality and compliance programs?
  • Obtaining patient-centric using RWE
  • What are complications that will rise by inserting new data source? Breakup in data?
  • Identify the challenges involved in incorporating real world evidence into a structured benefit-risk assessment.

JULIE BARBERIO

Director, Pharmacoepidemiology
Sanofi

10:10 – Keynote Panel Discussion: Reimagining Global Pharmacovigilance: From Today’s Challenges to Tomorrow’s Solutions

CHALLENGES & OPPORTUNITIES

Moderator:

MARIETTE BOERSTOEL-STREEFLAND

SVP, Worldwide Patient Safety Officer

Bristol-Myers Squibb

Panelists:

PHILISHA MACK

Sr. Director of Drug Safety, Medical Affairs

Azurity Pharmaceuticals

NICOLE SCHUMACHER-CROW

Continuous Improvement Center of Excellence Head –
Senior Director

Pfizer

MILIND SARDESA

Executive Director, Safety Surveillance, Global Patient
Safety,

Dicerna Pharmaceuticals

VASUDEV BHUPATHI

Director – Pharmacovigilance

Moderna

NAMITA JOSHI

Regional PV Head, North America

Sanofi

11:00 – Morning Networking Coffee/Tea & Discussion

 

11:30 – Gene therapy long-term safety management

PV IN GENE THERAPHY

MALLIKA SINGH

Associate Director, Pharmacovigilance
Genetix Biotherapeutics

12:00 – Solution Provider Presentation

For sponsorship opportunities please contact
info.uk@virtueinsight.com

12:30 – Networking luncheon

13:30 – Panel Discussion – Transforming Pharmacovigilance Through Technology: AI, Automation, and the Future of Drug Safety. Opportunities, Challenges & Lessons Learned

IMPACT OF TECHNOLOGY

Moderator:

HEATHER LEIGH FLANNERY

CEO & Co-Founder

AI MINDSystems Foundation

Panelists:

ALTON SARTOR

Medical Director, Patient Safety Physician Digital &
Devices

AstraZeneca

VIKALP KHARE

Director, Head of US GPV Safety Data Management

Otsuka Pharmaceutical

MICHAEL GLASER

Technology Innovation Director

GSK

PRIYANKA CHHIKARA

Head of Risk Management, Aggregate Reports & Data
Science

CSL Behring

14:20 – From Compliance to Excellence: The future of
Patient Safety

COMPLIANCE

  • Patient Safety, where are we and what has changed lately?
  • Fundamentals remain unchanged
  • Shift the focus
  • Implementation strategy
  • Conclusion and take aways

JULIE BARBERIO

Director, Pharmacoepidemiology
Sanofi

14:50 – Gene therapy, long-term follow-up, and Inspection readiness

GENE THERAPY / INSPECTION

  • Long-term follow-up requirements for Gene therapy
  • How to plan inspection readiness activities for Gene therapy.
  • Risk Management in Gene Therapy

KAPIL BHUTADA

Head of PV Safety Operation & Compliance
Asklepios BioPharmaceutical

15:20 – Afternoon Networking Coffee/Tea & Discussion

15:50 – The round table series

COLLABRATIVE BREAKOUT SESSIONS

Chairperson for all tables

BEN LOCWIN

VP Board of Directors
SOPPhC (VP, Reliant Life Sciences)

JYRKI SYVAERI

Corporate Director 

Boehringer Ingelheim

JYRKI SYVAERI

Corporate Director 

Boehringer Ingelheim

events sponsors

We wouldn’t be able to host our conferences without help from these amazing companies. A huge thanks to all our sponsors and partners!

Platinum

Pfizer

Pfizer

Amgen

Amgen

Gold

Pfizer

Pfizer

Takeda

Takeda

Takeda

Takeda

Silver

Pfizer

Pfizer

Brand Name

Brand Name

Novartis

Novartis

Novartis

Novartis

Takeda

Takeda

Takeda

Takeda

Teva

Teva

Teva

Teva

events TESTIMONIALS
event venue

Pullman Brussels Centre
Midi, Brussels, Belgium
Belgium

+32 2 528 98 00

Get Involved

Speaking Opportunities

Fen Castro
fen@virtueinsightevents.com
+91 44 42108101
Contact Now

Sponsorship &
Delegate Enquiry

Piyush Patel
piyush@virtueinsightevents.com
+44 20 3509 3779
Contact Now

Networking App

Kindly Note!
Access to view and connect with other attendees through our mobile app will be enabled closer to the conference date.
bookings

EARLY BIRD PRICE - INDIVIDUAL BOOKING

  • Entry to the Conference
  • Motivating keynote sessions, dynamic panel discussions, engaging Q&As, and more with key industry leaders
  • Valuable in-person networking and idea exchange with fellow professionals
  • Innovative insights and cutting edge solutions from top-tier providers
  • Full access to our networking platform
  • Receive Certificate of Attendance
  • Access to PDF presentations* via our website pending speaker permissions
  • Prices inclusive of 21% VAT

EARLY BIRD PRICE - INDIVIDUAL BOOKING

  • Entry to the Conference
  • Motivating keynote sessions, dynamic panel discussions, engaging Q&As, and more with key industry leaders
  • Valuable in-person networking and idea exchange with fellow professionals
  • Innovative insights and cutting edge solutions from top-tier providers
  • Full access to our networking platform
  • Receive Certificate of Attendance
  • Access to PDF presentations* via our website pending speaker permissions
  • Prices inclusive of 21% VAT

Ticket Types

Total: $0.00
Total $0.00

FOLLOW US

Subscribe now to receive updates on our events.

We strive to produce high quality conferences which include the latest topics which are delivered by world class leaders of the industry.

UK

Block 3, 86 Coombe Road
Croydon CR0 5RA
London, UK

+44 20 3509 3779

info.uk@virtueinsight.com

Asia

Plot No – 07 – 2nd Floor

Ekambaram Industrial Estate

Alapakkam, Porur Chennai,

India – 600 116

+91 44421 08101

info.uk@virtueinsight.com

Quick Links

HOME
ABOUT US
EVENTS
EVENT SUPPORT
FAQ

CONTACT US
PRIVACY POLICY
TERMS & CONDITIONS

STAY INFORMED

Subscribe now to receive updates on our events